Dilated cardiomyopathy: an anaesthetic challenge
- PMID: 23905133
- PMCID: PMC3708228
- DOI: 10.7860/JCDR/2013/5390.3069
Dilated cardiomyopathy: an anaesthetic challenge
Abstract
Idiopathic dilated cardiomyopathy is a primary myocardial disease of unknown etiology characterized by left ventricular or biventricular dilation and impaired contractility. Depending upon diagnostic criteria used, the reported annual incidence varies between 5 and 8 cases per 100,000 populations. Dilated cardiomyopathy is defined by presence of: a) fractional myocardial shortening less than 25% (>2SD) and/or ejection fraction less than 45% (>2SD) and b) Left Ventricular End Diastolic Diameter (LVEDD) greater than 117% excluding any known cause of myocardial disease. Such cases are always a challenge to the anesthesiologist as they are most commonly complicated by progressive cardiac failure. We report the anesthetic management of a patient with dilated cardiomyopathy undergoing surgery for carcinoma breast.
Keywords: Anaesthetic management; Dilated cardiomyopathy; Idiopathic.
Figures
References
-
- Stevenson LW, Perloff JK. The Dilated cardiomyopathy: clinical aspects. Cardiol Clin. 1988;6:187–218. - PubMed
-
- Stoelting RK, Dierdorf SF. Anaesthesia and Coexisting Disease. (3rd ed) New York: Churchill Livingstone; 1993. Cardiomyopathy. In: Stoelting RK (Ed) pp. 97–102.
-
- Molhoek SG, Bax JJ, Erven RV. Effectiveness of resynchronization therapy in patients with end stage heart failure. Am J Cardiol. 2002;90:379–83. - PubMed
-
- Schechter WS, Kim C, Martinez M. Anesthetic induction in a child with end-stage cardiomyopathy. Can J Anaesth. 1995;42:404–08. - PubMed
-
- Sharma R, Francis DP, Pitt B. Hemoglobin perdicts survival in patients with chronic heart failure: a sub study of the ELITE II trial. Eur Heart J. 2004;25(12):1021–28. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources